JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -125.36%-2.65B | 29.88%-9B | 37.83%-1.17B | -651.98%-12.84B | -179.03%-1.89B | -60.07%2.33B | 0.28%2.39B | 15.81%5.83B | 21.29%2.38B | 21.91%5.03B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 74.61%-9.13M | 60.41%-50.81M | 58.16%-35.98M | 75.35%-128.35M | 72.70%-85.99M | ---520.68M | 0.90%-315M | ---- | -136.47%-317.86M | -37.01%-373.26M |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---11.53M | ---3.53M | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | -115.39%-4.58M | -30.36%177.88M | 121.81%29.77M | 194.38%255.42M | -122.15%-136.51M | 53.27%-270.62M | 83.23%-61.45M | -11.18%-579.16M | -413.73%-366.4M | -429.80%-520.93M |
Impairment and provisions: | 234.30%1.32B | -43.30%5.8B | -75.04%394.21M | 775.58%10.23B | 1,041.16%1.58B | 1,148.37%1.17B | 50.72%138.41M | 158.24%93.63M | 248.16%91.83M | -260.10%-160.76M |
-Impairment of property, plant and equipment (reversal) | 573.37%1.2B | -47.88%4.38B | -79.82%177.99M | 623.14%8.4B | 562.16%881.98M | 1,211.27%1.16B | 46.39%133.2M | 154.91%88.54M | 246.42%90.99M | -157.02%-161.25M |
-Other impairments and provisions | -44.81%119.34M | -22.40%1.43B | -69.00%216.22M | 23,421.18%1.84B | 13,270.71%697.55M | 53.63%7.82M | 514.49%5.22M | 955.39%5.09M | 437.34%849K | 100.26%482K |
Revaluation surplus: | 69.24%225.6M | 60.66%898.57M | -64.91%133.3M | 118.79%559.29M | 2,686.04%379.92M | 156.47%255.63M | 60.96%-14.69M | -45.09%-452.66M | 58.21%-37.64M | -38.66%-311.99M |
-Fair value of investment properties (increase) | 86.16%225.6M | 56.96%644.42M | -54.48%121.18M | 104.06%410.57M | 5,236.81%266.24M | 162.11%201.2M | 93.49%-5.18M | 0.78%-323.96M | 35.40%-79.62M | -125.86%-326.51M |
-Other fair value changes | ---- | 70.89%254.16M | -89.34%12.12M | 173.24%148.72M | 1,295.56%113.67M | 142.29%54.43M | -122.65%-9.51M | -986.77%-128.7M | 26.52%41.98M | 118.04%14.51M |
Asset sale loss (gain): | -99.97%86K | 52.62%30.32M | 733.71%307.24M | 102.35%19.87M | 94.48%-48.48M | -435.07%-844.96M | -1,689.46%-879.02M | -183.28%-157.92M | -265.18%-49.12M | -380.78%-55.75M |
-Loss (gain) from sale of subsidiary company | ---- | -60.71%25.24M | 820.32%307.77M | 107.34%64.25M | 94.99%-42.73M | -774.94%-875.62M | -6,598.59%-853.2M | -82.09%-100.08M | -817.65%-12.74M | -372.13%-54.96M |
-Loss (gain) on sale of property, machinery and equipment | 99.96%-1K | -83.05%-4.43M | -258.65%-2.55M | -242.63%-2.42M | -2,121.88%-711K | 74.36%-706K | -200.00%-32K | -250.83%-2.75M | 420.00%32K | -1,806.52%-785K |
-Loss (gain) from selling other assets | -95.69%87K | 122.65%9.5M | 140.02%2.02M | -233.81%-41.97M | 80.43%-5.05M | 156.93%31.36M | 29.20%-25.79M | ---55.09M | -216.96%-36.42M | ---- |
Depreciation and amortization: | -7.53%25.79M | -23.05%57.53M | -34.29%27.89M | -35.20%74.76M | -21.48%42.44M | 6.63%115.38M | 9.51%54.04M | 1.30%108.2M | -18.28%49.35M | 217.20%106.81M |
-Amortization of intangible assets | -45.45%6K | -86.11%20K | -89.91%11K | -95.05%144K | -95.78%109K | -3.77%2.91M | 199.07%2.58M | -38.38%3.02M | -68.79%863K | 10.57%4.91M |
Financial expense | 132.36%1.56B | 88.92%2.59B | 75.10%673.39M | 112.42%1.37B | 8.14%384.57M | --645.12M | 15.80%355.62M | ---- | 47.89%307.09M | 26.90%484.09M |
Special items | ---- | ---- | ---- | -129.79%-47.38M | -96.41%-47.38M | 831.04%159.01M | -113.45%-24.12M | ---21.75M | ---11.3M | ---- |
Operating profit before the change of operating capital | 33.39%474.7M | 199.31%500.4M | 98.05%355.89M | -116.67%-503.88M | -89.04%179.69M | -37.26%3.02B | -19.96%1.64B | 14.70%4.82B | 7.57%2.05B | -2.06%4.2B |
Change of operating capital | ||||||||||
Developing property (increase)decrease | 53.20%21.78B | 342.00%25.44B | 158.73%14.21B | 165.97%5.76B | 172.53%5.49B | 56.89%-8.72B | 34.39%-7.57B | 12.68%-20.24B | -476.62%-11.55B | -113.36%-23.18B |
Accounts receivable (increase)decrease | 528.45%152.96M | 1,523.06%147.9M | -446.78%-35.7M | 98.48%-10.39M | 124.75%10.3M | -2,131.76%-683.16M | 31.10%-41.6M | 120.59%33.62M | 11.36%-60.38M | -173.22%-163.28M |
Accounts payable increase (decrease) | 88.57%-185.16M | 178.35%3.28B | -190.75%-1.62B | -89.84%1.18B | -66.64%1.79B | -20.92%11.62B | -28.38%5.35B | -1.79%14.69B | 643.59%7.47B | 151.55%14.96B |
prepayments (increase)decrease | -36.00%1.19B | 126.40%1.71B | 127.25%1.86B | 36.16%-6.48B | 38.98%-6.84B | -51.27%-10.14B | -379.45%-11.2B | -415.50%-6.71B | 56.38%-2.34B | 355.37%2.13B |
Special items for working capital changes | -88.47%-23.39B | -1,681.88%-28.6B | -463.09%-12.41B | -89.99%1.81B | -76.77%3.42B | 64.19%18.06B | 137.56%14.71B | 263.51%11B | 893.08%6.19B | -285.80%-6.73B |
Adjustment items for working capital changes | ---950K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from business operations | -98.96%24.58M | 41.62%2.48B | -41.54%2.37B | -86.67%1.75B | 40.43%4.05B | 335.35%13.15B | 62.89%2.88B | 134.40%3.02B | 133.43%1.77B | -517.92%-8.78B |
Other taxs | 52.00%-184.02M | 66.44%-346.58M | 55.74%-383.42M | 46.92%-1.03B | 46.07%-866.26M | -14.16%-1.95B | -51.54%-1.61B | -1.07%-1.7B | 3.35%-1.06B | -9.54%-1.69B |
Interest received - operating | -74.61%9.13M | -60.41%50.81M | -58.16%35.98M | -75.35%128.35M | -72.70%85.99M | --520.68M | -0.90%315M | --0 | 136.47%317.86M | 37.01%373.26M |
Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13.48%-3.97B |
Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --578.68M | ---- | ---- |
Adjustment items of business operations | --50K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | -107.44%-150.26M | 157.60%2.19B | -38.22%2.02B | -92.76%849.2M | 105.27%3.27B | 518.71%11.73B | 54.87%1.59B | 113.48%1.9B | 113.32%1.03B | -427.93%-14.06B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | --3.53M | ---- | ---- | ---- |
Sale of fixed assets | -99.86%7K | 130.31%7.37M | 408.71%5.08M | 126.63%3.2M | 56.09%999K | -72.59%1.41M | -81.22%640K | 69.72%5.15M | 760.35%3.41M | 168.11%3.04M |
Purchase of fixed assets | 99.96%-14K | 97.92%-1.7M | 50.09%-36.51M | -383.38%-81.58M | -907.66%-73.15M | 50.46%-16.88M | -6.33%-7.26M | 7.39%-34.07M | 70.68%-6.83M | 70.86%-36.79M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | 39.02%-700K | -63.76%-750K | 37.23%-1.15M | -27.22%-458K | 75.07%-1.83M |
Sale of subsidiaries | ---- | -95.82%109M | 22.04%564M | 200.22%2.61B | 114.56%462.14M | -1,281.47%-2.6B | -2,519.24%-3.17B | 63.06%-188.17M | -8,925.35%-121.17M | -2,219.39%-509.4M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -34.04%1.48B | -97.42%21.2M | 3,710.89%2.24B | 1,297.62%822.95M | -83.97%58.88M |
Recovery of cash from investments | -79.95%2.64M | -69.40%38.71M | -78.48%13.17M | -78.88%126.51M | 137.35%61.2M | 1,554.70%599.15M | 131.03%25.79M | -95.92%36.21M | -85.54%11.16M | 17,661.34%888.07M |
Cash on investment | ---- | 84.57%-23.92M | 70.25%-15.18M | 97.78%-155.03M | 84.55%-51.04M | -71.64%-6.98B | 87.47%-330.42M | -55.56%-4.06B | -75.85%-2.64B | 30.96%-2.61B |
Other items in the investment business | ---1.48M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -99.78%1.15M | -94.82%129.47M | 32.59%530.57M | 133.25%2.5B | 111.56%400.16M | -275.17%-7.51B | -79.60%-3.46B | 9.42%-2B | -39.16%-1.93B | 37.21%-2.21B |
Net cash before financing | -105.84%-149.11M | -30.78%2.32B | -30.50%2.55B | -20.55%3.35B | 296.58%3.67B | 4,028.67%4.21B | -107.94%-1.87B | 99.34%-107.25M | 90.14%-898.09M | -163.14%-16.27B |
Cash flow from financing activities | ||||||||||
New borrowing | -199.64%-199.71M | 432.07%1.21B | 202.13%200.44M | -101.79%-363.4M | -102.12%-196.26M | 19.78%20.34B | -18.05%9.24B | 219.36%16.99B | -35.42%11.28B | -18.45%-14.23B |
Refund | 98.45%-29.29M | 74.96%-3.9B | 90.14%-1.89B | 51.18%-15.58B | -45.03%-19.17B | -232.67%-31.91B | -36.36%-13.22B | -148.56%-9.59B | 41.29%-9.69B | 173.12%19.76B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.99%1.07B |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | -16.38%12.48B | -2.53%8.78B | -17.57%14.93B | -4.15%9.01B | 80.24%18.11B |
Interest paid - financing | 88.89%-91.16M | 53.96%-994.98M | 53.51%-820.68M | 66.40%-2.16B | 41.00%-1.77B | -35.42%-6.43B | -21.07%-2.99B | ---4.75B | ---2.47B | ---- |
Dividends paid - financing | ---- | ---- | -0.89%-192.41M | -2.45%-753.51M | 4.40%-190.72M | 42.30%-735.48M | 46.38%-199.5M | -69.35%-1.27B | ---372.07M | 4.20%-752.66M |
Absorb investment income | ---- | ---- | ---- | -99.16%78.51M | ---- | 9.43%9.4B | 142.05%9.26B | 71.98%8.59B | 55.49%3.83B | -29.63%4.99B |
Issuance expenses and redemption of securities expenses | ---3.32M | 98.64%-3.75M | ---- | 97.82%-275.46M | 98.06%-147.28M | -2.44%-12.64B | -70.39%-7.57B | -86.30%-12.34B | -316.15%-4.45B | -575.00%-6.62B |
Pledged bank deposit (increase) decrease | ---- | -99.94%4.25M | -99.94%4.27M | 194.78%7.3B | 55,982.75%6.9B | -11,751.74%-7.7B | --12.3M | 53.80%-64.98M | ---- | -257.12%-140.65M |
Other items of the financing business | 99.08%-250K | 94.12%-181.96M | 96.12%-27.28M | 59.69%-3.09B | 61.84%-702.52M | -61.06%-7.67B | -53.68%-1.84B | -2,649.62%-4.76B | -1,165.67%-1.2B | 33.26%-173.28M |
Net cash from financing operations | 87.85%-332.25M | 73.93%-3.87B | 82.10%-2.74B | 40.30%-14.85B | -1,145.01%-15.28B | -423.82%-24.87B | -75.25%1.46B | -65.04%7.68B | -49.19%5.91B | 55.82%21.97B |
Effect of rate | -89.64%239K | -97.71%1.03M | -89.98%2.31M | 149.44%45.16M | 125.22%23.03M | 80.34%-91.34M | -145.58%-91.34M | -454.77%-464.55M | 1,865.71%200.4M | 59.37%130.95M |
Net Cash | -161.70%-481.36M | 86.49%-1.55B | 98.42%-183.94M | 44.32%-11.5B | -2,768.30%-11.61B | -372.77%-20.66B | -108.08%-404.89M | 32.91%7.57B | 98.66%5.01B | -28.02%5.7B |
Begining period cash | -47.50%1.72B | -77.80%3.27B | -77.80%3.27B | -58.49%14.73B | -58.49%14.73B | 25.06%35.48B | 25.06%35.48B | 25.86%28.37B | 25.86%28.37B | 55.02%22.54B |
Cash at the end | -59.99%1.24B | -47.50%1.72B | -1.54%3.09B | -77.80%3.27B | -91.03%3.14B | -58.49%14.73B | 4.17%34.98B | 25.06%35.48B | 33.94%33.58B | 25.86%28.37B |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | --44.45B | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | --44.45B | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.